According to Y-mAbs Therapeutics 's latest financial reports the company's current revenue (TTM ) is $85.38 Million USD. In 2024 the company made a revenue of $87.68 Million USD an increase over the revenue in the year 2023 that were of $84.81 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.